Tumor necrosis factor signaling

Cell Death and Differentiation

Volumn 10, Issue 1, 2003, Pages 45-65

  Wajant, H ^a   Pfizenmaier, K ^a   Scheurich, P ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Apoptosis; IKK; immunity; JNK; Necrosis; NF B; TNF; TRAF2

Indexed keywords

CASPASE; CATHEPSIN B; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CELL DEATH; CYTOTOXICITY; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; LIGAND BINDING; MEDLINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037276438     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401189     Document Type: Review

References (337)

1. Kriegler M, Perez C, DeFay K et al. (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45-53
2. Tang P, Hung M-C and Klostergaard J (1996) Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35: 8216-8225
3. Black RA, Rauch CT, Kozlosky CJ et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733
4. Bazan JF (1993) Emerging families of cytokines and receptors. Curr. Biol. 3: 603-606
5. Locksley RM, Killeen N and Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501
6. Naismith JH and Sprang SR (1998) Modularity in the TNF-receptor family. Trends Biochem. Sci. 23: 74-79
7. Banner DW, D'Arcy A, Janes W et al. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73: 431-445
8. Chan FK, Chun HJ, Zheng L et al. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288: 2351-2354
9. Grell M, Douni E, Wajant H et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802
10. Grell M, Wajant H, Zimmermann G and Scheurich P (1998) The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. USA 95: 570-575
11. Wallach D, Engelmann H, Nophar Y et al. (1991) Soluble and cell surface receptors for tumor necrosis factor. Agents Actions Suppl. 35: 51-57
12. Taylor PC (2001) Anti-tumor necrosis factor therapies. Curr. Opin. Rheumatol. 13: 164-169
13. Solomon KA, Pesti N, Wu G and Newton RC (1999) Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J. Immunol. 163: 4105-4108
14. McDermott MF, Aksentijevich I, Galon J et al. (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97: 133-144
15. Tartaglia LA, Ayres TM, Wong GH and Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853
16. Schulze-Osthoff K, Ferrari D, Los M et al. (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254: 439-459
17. Mannel DN and Echtenacher B (2000) TNF in the inflammatory response. Chem. Immunol. 74: 141-161
18. Beutler B, Greenwald D, Hulmes JD et al. (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552-554
19. Probert L, Akassoglou K, Pasparakis M et al. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 92: 11294-11298
20. Fontaine V, Mohand-Said S, Hanoteau N et al. (2002) Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22: RC216
21. Kontoyiannis D, Pasparakis M, Pizarro TT et al. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398
22. Yamada Y, Kirillova I, Peschon JJ and Fausto N (1997) Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94: 1441-1446
23. Bradham CA, Plumpe J, Manns MP et al. (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol. 275: G387-G392
24. Taylor PC, Peters AM, Paleolog E et al. (2000) Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 43: 38-47
25. Blam ME, Stein RB and Lichtenstein GR (2001) Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives. Am. J. Gastroenterol. 96: 1977-1997
26. Chaplin DD and Fu Y (1998) Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10: 289-297
27. Ruddle NH (1999) Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19: 119-125
28. Marino MW, Dunn A, Grail D et al. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 194: 8093-8098
29. Flynn JL, Goldstein MM, Chan J et al. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572
30. Rothe J, Mackay F, Bluethmann H et al. (1994) Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR1-deficient fibroblasts in vitro. Circ. Shock 44: 51-56
31. Vieira LQ, Goldschmidt M, Nashleanas M et al. (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157: 827-835
32. Bean AG, Roach DR, Briscoe H et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162: 3504-3511
33. Deckert-Schluter M, Bluethmann H, Rang A et al. (1998) Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol. 160: 3427-3436
34. Camelo S, Lafage M and Lafon M (2000) Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. J. Neurovirol. 6: 507-518
35. Zhao YX, Lajoie G, Zhang H et al. (2000) Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance. Infect. Immun. 68: 1243-1251
36. Lucas R, Juillard P, Decoster E et al. (1997) Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane- bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27: 1719-1725
37. Kollias G, Douni E, Kassiotis G and Kontoyiannis D (1999) On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169: 175-194
38. Wagner TE, Huseby ES and Huseby JS (2002) Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor. Am. J. Med. 112: 67-69
39. Old LJ (1988) Tumor necrosis factor. Sci. Am. 258: 59-75
40. Sugarman BJ, Aggarwal BB, Hass PE et al. (1985) Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945
41. Hock H, Dorsch M, Kunzendorf U et al. (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc. Natl. Acad. Sci. USA 90: 2774-2778
42. Eggermont AM and ten Hagen TL (2001) Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives. Curr. Oncol. Rep. 3: 359-367
43. Ruegg C, Yilmaz A and Bieler G et al. (1998) Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat. Med. 4: 408-414
44. Baud V and Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11: 372-377
45. Verma IM, Stevenson JK, Schwarz EM et al. (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9: 2723-2735
46. Perkins ND (2000) The Rel/NF-kappa B family: friend and foe. Trends Biochem. Sci. 25: 434-440
47. Mercurio F, Zhu H, Murray BW et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866
48. DiDonato JA, Hayakawa M, Rothwarf DM et al. (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554
49. Zandi E, Rothwarf DM, Delhase M et al. (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252
50. Yamaoka S, Courtois G, Bessia C et al. (1998) Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93: 1231-1240
51. Li Y, Kang J, Friedman J et al. (1999) Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc. Natl. Acad. Sci. USA 96: 1042-1047
52. Rothwarf DM, Zandi E, Natoli G and Karin M (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297-300
53. Harhaj EW, Good L, Xiao G et al. (2000) Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 19: 1448-1456
54. Mercurio F, Murray BW, Shevchenko A et al. (1999) IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell Biol. 19: 1526-1538
55. Chen G, Cao P and Goeddel DV (2002) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell 9: 401-410
56. Rudolph D, Yeh WC, Wakeham A et al. (2000) Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14: 854-862
57. Schmidt-Supprian M, Bloch W, Courtois G et al. (2000) NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell 5: 981-992
58. Makris C, Godfrey VL, Krahn-Senftleben G et al. (2000) Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5: 969-979
59. Tanaka M, Fuentes ME, Yamaguchi K et al. (1999) Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10: 421-429
60. Li Q, Van Antwerp D, Mercurio F et al. (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284: 321-325
61. Takeda K, Takeuchi O, Tsujimura T et al. (1999) Limb and skin abnormalities in mice lacking IKKalpha. Science 284: 313-316
62. Hu Y, Baud V, Delhase M et al. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284: 316-320
63. Li Q, Lu Q, Hwang JY et al. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13: 1322-1328
64. Senftleben U, Cao Y, Xiao G et al. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499
65. Xiao G, Cvijic ME, Fong A et al. (2001) Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 20: 6805-6815
66. Li Q, Estepa G, Memet S et al. (2000) Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14: 1729-1733
67. Pomerantz JL and Baltimore D (1999) NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18: 6694-6704
68. Bonnard M, Mirtsos C, Suzuki S et al. (2000) Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19: 4976-4985
69. Tojima Y, Fujimoto A, Delhase M et al. (2000) NAK is an IkappaB kinase-activating kinase. Nature 404: 778-782
70. Peters RT, Liao SM and Maniatis T (2000) IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol. Cell 5: 513-522
71. Jiang Y, Woronicz JD, Liu W and Goeddel DV (1999) Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283: 543-546
72. Hsu H, Xiong J and Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF- kappa B activation. Cell 81: 495-504
73. Hsu H, Huang J, Shu HB et al. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor- 1 signaling complex. Immunity 4: 387-396
74. Wajant H, Henkler F, Scheurich P (2001) The TNF-receptor-associated factor family. Scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal. 13: 389-400
75. Hsu H, Shu HB, Pan MG and Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308
76. Devin A, Cook A, Lin Y et al. (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12: 419-429
77. Zhang SQ, Kovalenko A, Cantarella G and Wallach D (2000) Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12: 301-311
78. Davin A, Lin Y, Yamaoka S et al. (2001) The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2- dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell Biol. 21: 3986-3994
79. Ting AT, Pimentel-Muinos FX and Seed B (1996) RIP mediates tumor necrosis factor receptor 1 activation of NE-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15: 6189-6196
80. Yang J, Lin Y, Guo Z et al. (2001) The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat. Immunol. 2: 620-624
81. Baud V, Liu ZG, Bennett B et al. (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13: 1297-1308
82. Kim JW, Joe CO and Choi EJ (2001) Role of receptor-interacting protein in tumor necrosis factor-alpha-dependent MEKK1 activation. J. Biol. Chem. 276: 27064-27070
83. Xia Y, Makris C, Su B et al. (2000) MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA 97: 5243-5248
84. Yujiri T, Ware M, Widmann C et al. (2000) MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc. Natl. Acad. Sci. USA 97: 7272-7277
85. Sanz L, Diaz-Meco MT, Nakano H and Moscat J (2000) The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL1-TRAF6 pathway. EMBO J. 19: 1576-1586
86. Leitges M, Sanz L, Martin P et al. (2001) Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol. Cell 8: 771-780
87. Anrather J, Csizmadia V, Soares MP and Winkler H (1999) Regulation of NF-kappaB ReIA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells. J. Biol. Chem. 274: 13594-13603
88. Zhong H, SuYang H, Erdjument-Bromage H et al. (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424
89. Lallena MJ, Diaz-Meco MT, Bren G et al. (1999) Activation of IkappaB kinase beta by protein kinase C isoforms. Mol. Cell Biol. 19: 2180-2188
90. Sanz L, Sanchez P, Lallena MJ et al. (1999) The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 18: 3044-3053
91. Wang D, Westerheide SD, Hanson JL and Baldwin AS (2000) Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275: 32592-32597
92. Sizemore N, Lerner N, Dombrowski N et al. (2002) Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J. Biol. Chem. 277: 3863-3869
93. Ozes ON, Mayo LD, Gustin JA et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85
94. Romashkova JA and Makarov SS (1999) NF-kappaB is a target of AKT in antiapoptotic PDGF signalling. Nature 401: 86-90
95. Hanna AN, Chan EY, Xu J et al. (1999) A novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase. J. Biol. Chem. 274: 12722-12729
96. Kim BC, Lee MN, Kim JY et al. (1999) Roles of phosphatidylinositol 3-kinase and Rac in the nuclear signaling by tumor necrosis factor-alpha in rat-2 fibroblasts. J. Biol. Chem. 274: 24372-24377
97. Reddy SA, Huang JH and Liao WS (2000) Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J. Immunol. 164: 1355-1363
98. Pastorino JG, Tafani M and Farber JL (1999) Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J. Biol. Chem. 274: 19411-19416
99. Plo I, Lautier D, Levade T et al. (2000) Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells. Biochem. J. 351: 459-467
100. Osawa Y, Banno Y, Nagaki M et al. (2001) TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J. Immunol. 167: 173-180
101. Martin AG, San Antonio B and Fresno M (2001) Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha. J. Biol. Chem. 276: 15840-15849
102. Mayo MW, Madrid LV, Westerheide SD at al. (2002) PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J. Biol. Chem. 277: 11116-11125
103. Gustin JA, Maehama T, Dixon JE and Donner DB. (2001) The PTEN tumor suppressor protein inhibits tumor necrosis factor- induced nuclear factor kappa B activity. J. Biol. Chem. 276: 27740-27744
104. Madrid LV, Mayo MW, Reuther JY and Baldwin Jr AS (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276: 18934-18940
105. Burkle A (2001) Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett. 163: 1-5
106. Oliver FJ, Menissier-de Murcia J, Nacci C at al. (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18: 4446-4454
107. Hasse PO and Hottiger MO (1999) A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. Biol. Chem. 380: 953-959
108. Hassa PO, Covic M, Hasan S at al. (2001) The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276: 45588-45597
109. Chang WJ and Alvarez-Gonzalez R (2001) The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J. Biol. Chem. 276: 47664-47670
110. Ullrich O, Diestel A, Eyupoglu IY, Nitsch R (2001) Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat. Cell Biol. 3: 1035-1042
111. Le Page C, Sanceau J, Drapier JC, Wetzerbin J (1998) Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem. Biophys. Res. Commun. 243: 451-457
112. Kameoka M, Ota K, Tetsuka T at al. (2000) Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochem. J. 346: 641-649
113. Ha HC, Hester LD, Snyder SH (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. USA 99: 3270-3275
114. Hoeflich KP, Luo J, Rubie EA at al. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90
115. Higuchi M and Aggarwal BB (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 152: 3550-3558
116. Mosselmans R, Hepbum A, Dumont JE at al. (1988) Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J. Immunol. 141: 3096-3100
117. Schutze S, Machleidt T, Adam D at al. (1999) Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274: 10203-10212
118. Beg AA, Sha WC, Bronson RT and Baltimore D (1995) Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 9: 2736-2746
119. Sarma V, Lin Z, Clark L at al. (1995) Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270: 12343-12346
120. Song HY, Rothe M and Goeddel DV (1996) The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc. Natl. Acad. Sci. USA 93: 6721-6725
121. Lee EG, Boone DL, Chai S at al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354
122. Zetoune FS, Murthy AR, Shao Z at al. (2001) A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome. Cytokine 15: 282-298
123. Heyninck K, De Valck D, Vanden Berghe W at al. (1999) The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J. Cell Biol. 145: 1471-1482
124. Jaattela M, Mouritzen H, Elling F and Bastholm L (1996) A20 zinc finger protein inhibits TNF and IL1 signaling. J. Immunol. 156: 1166-1173
125. Delhase M, Hayakawa M, Chen Y and Karin M (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309-313
126. Shaulian E and Karin M (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: 131-136
127. Chang L and Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37-40
128. Brenner DA, O'Hara M, Angel P at al. (1989) Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337: 661-663
129. Hanazawa S, Takeshita A, Amano S at al. (1993) Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268: 9526-9532
130. Min W and Pober JS (1997) TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. J. Immunol. 159: 3508-3518
131. Diehl AM, Yin M, Fleckenstein J at al. (1994) Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am. J. Physiol. 267: G552-G561
132. Bruccoleri A, Gallucci R, Germolec DR at al. (1997) Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25: 133-141
133. Reinhard C, Shamoon B, Shyamala V and Williams LT (1997) Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16: 1080-1092
134. Natoli G, Costanzo A, Ianni A at al. (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203
135. Liu ZG, Hsu H, Goeddell DV, Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576
136. Song HY, Regnier CH, Kirschning CJ at al. (1997) Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94: 9792-9796
137. Lee SY, Reichlin A, Santana A at al. (1997) TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7: 703-713
138. Yeh WC, Shahinian A, Speiser D at al. (1997) Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725
139. Tournier C, Dong C, Turner TK et al. (2001) MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15: 1419-1426
140. Lawler S, Fleming Y, Goedert M and Cohen P (1998) Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol. 8: 1387-1390
141. Moriguchi T, Toyoshima F, Masuyama N at al. (1997) A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 16: 7045-7053
142. Nishitoh H, Saitoh M, Mochida Y et al. (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2: 389-395
143. Hoeflich KP, Yeh WC, Yao Z at al. (1999) Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 18: 5814-5820
144. Tobiume K, Matsuzawa A, Takahashi T at al. (2001). ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2: 222-228
145. Kyriakis JM (1999) Signaling by the germinal center kinase family of protein kinases. J. Biol. Chem. 274: 5259-5262
146. Yuasa T, Ohno S, Kehrl JH and Kyriakis JM (1998) Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273: 22681-22692
147. Diener K, Wang XS, Chen C at al. (1997) Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc. Natl. Acad. Sci. USA 94: 9687-9692
148. Shi CS and Kehrl JH (1997) Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J. Biol. Chem. 272: 32102-32107
149. Yao Z, Zhou G, Wang XS et al. (1999) A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. J. Biol. Chem. 274: 2118-2125
150. Nakano K, Yamauchi J, Nakagawa K et al. (2000) NESK, a member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and is expressed during the late stages of embryogenesis. J. Biol. Chem. 275: 20553-20559
151. Fu CA, Shen M, Huang BC et al. (1999) TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J. Biol. Chem. 274: 30729-30737
152. Shi CS, Leonardi A, Kyriakis J et al. (1999) TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related. J. Immunol. 163: 3279-3285
153. Chadee DN, Yuasa T and Kyriakis JM (2002) Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol. Cell Biol. 22: 737-749
154. Ichijo H, Nishida E, Irie K et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94
155. Chandel NS, Schumacker PT and Arch RH (2001) Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J. Biol. Chem. 276: 42728-42736
156. Gotoh Y and Cooper JA (1998) Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J. Biol. Chem. 273: 17477-17482
157. Saitoh M, Nishitoh H, Fujii M et al. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17: 2596-2606
158. Matsuda M, Masutani H, Nakamura H et al. (1991) Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147: 3837-3841
159. Liu H, Nishitoh H, Ichijo H and Kyriakis JM (2000) Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol. Cell Biol. 20: 2198-2208
160. Carpentier I, Declercq W, Malinin NL et al. (1998) TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkappaB kinase pathways. FEBS Lett. 425: 195-198
161. Pombo CM, Kehrl JH, Sanchez I et al. (1995) Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature 377: 750-754
162. Kelliher MA, Grimm S, Ishida Y et al. (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8: 297-303
163. Wysk M, Yang DD, Lu HT et al. (1999) Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96: 3763-3768
164. Martin-Blanco E (2000) p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 22: 637-645
165. Winzen R, Kracht M, Ritter B et al. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18: 4969-4980
166. Miyazawa K, Mori A, Miyata H et al. (1998) Regulation of interleukin 1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273: 24832-24838
167. Vanden Berghe W, Plaisance S, Boone E et al. (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273: 3285-3290
168. Beyaert R, Cuenda A, Vanden Berghe W et al. (1996) The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15: 1914-1923
169. Adam-Klages S, Adam D, Wiegmann K et al. (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937-947
170. Kreder D, Krut O, Adam-Klages S et al. (1999) Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18: 2472-2479
171. Bourteele S, Hausser A, Doppler H et al. (1998) Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells. J. Biol. Chem. 273: 31245-31251
172. Segui B, Cuvillier O, Adam-Klages S et al. (2001) Involvement of FAN in TNF-induced apoptosis. J. Clin. Invest. 108: 143-151
173. Luschen S, Adam D, Ussat S et al. (2000) Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN. Biochem. Biophys. Res. Commun. 274: 506-512
174. Boldin MP, Mett IL, Wallach D (1995) A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett. 367: 39-44
175. Tsurumi C, Shimizu Y, Seeki M et al. (1996) cDNA cloning and functional analysis of the p97 subunit of the 26S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55.11. Eur. J. Biochem. 239: 912-921
176. Dunbar JD, Song HY, Guo D et al. (1997) Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease. J. Immunol. 158: 4252-4259
177. Song HY, Dunbar JD, Zhang YX et al. (1995) Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270: 3574-3581
178. Felts SJ, Owen BA, Nguyen P et al. (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J. Biol. Chem. 275: 3305-3312
179. Van Lint J, Agostinis P, Vandevoorde V et al. (1992) Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. Implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor necrosis factor signal transduction pathway. J. Biol. Chem. 267: 25916-25921
180. Vietor I, Schwenger P, Li W et al. (1993) Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem. 268: 18994-18999
181. Muller G, Storz P, Bourteele S et al. (1998) Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J. 17: 732-742
182. Jupp OJ, McFarlane SM, Anderson HM et al. (2001) Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N- terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem. J. 359: 525-535
183. Schievella AR, Chen JH, Graham JR and Lin LL (1997) MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272: 12069-12075
184. Brown TL and Howe PH (1998) MADD is highly homologous to a Rab3 guanine-nucleotide exchange protein (Rab3-GEP). Curr. Biol. 8: R191
185. Chow VT and Lee SS (1996) DENN, a novel human gene differentially expressed in normal and neoplastic cells. DNA Seq. 6: 263-273
186. Hildt E and Oess S (1999) Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. J. Exp. Med., 189: 1707-1714
187. Yao B, Zhang Y, Delikat S et al. (1995) Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307-310
188. Lee SE, Chung WJ, Kwak HB et al. (2001) Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J. Biol. Chem. 276: 49343-49349
189. Landry DW and Oliver JA (2001) The pathogenesis of vasodilatory shock. N. Engl. J. Med. 345: 588-595
190. Wajant H, Haas E, Schwenzer R et al. (2000) Inhibition of death receptor-mediated gene induction by a cycloheximide- sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J. Biol. Chem. 275: 24357-24366
191. Varfolomeev EE, Schuchmann M, Luria V et al. (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276
192. Sanchez I, Xu CJ, Juo P et al. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22: 623-633
193. Zhang J, Cado D, Chen A et al. (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296-300
194. Yeh WC, Pompa JL, McCurrach ME et al. (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954-1958
195. Kischkel FC, Lawrence DA, Chuntharapai A et al. (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611-620
196. Sprick MR, Weigand MA, Rieser E et al. (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 1669. Immunity 12: 599-609
197. Bodmer JL, Holler N, Reynard S et al. (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2: 241-243
198. Juo P, Woo MS, Kuo CJ et al. (1999) FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth Differ. 10: 797-804
199. Juo P, Kuo CJ, Yuan J and Blenis J (1998) Essential requirement for caspase-8/FLICE in the initiation of the Fas- induced apoptotic cascade. Curr. Biol. 8: 1001-1008
200. Chinnaiyan AM, O'Rourke K, Tewari M, and Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512
201. Boldin MP, Goncharov TM, Goltsev YV and Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815
202. Muzio M, Chinnaiyan AM, Kischkel FC et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
203. Algeciras-Schimnich A, Shen L, Barnhart BC et al. (2002) Molecular ordering of the initial signaling events of CD95. Mol. Cell Biol. 22: 207-220
204. Weiss T, Grell M, Hessabi B et al. (1997) Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 158: 2398-2404
205. Weiss T, Grell M, Siemienski K et al. (1998) TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol. 161: 3136-3142
206. Duckett CS and Thompson CB (1997) CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11: 2810-2821
207. Li X, Yang Y and Ashwell JD (2002) TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416: 345-347
208. Chan FK and Lenardo MJ (2000) A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur. J. Immunol. 30: 652-660
209. Brown KD, Hostager BS and Bishop GA (2002) Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277: 19433-19438
210. Fotin-Mleczek M, Henkler F, Samel D et al. (2002) Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J. Cell Sci. 115: 2757-2770
211. Shu HB, Takeuchi M and Goeddel DV (1996) The tumor necrosis factor receptor 2 signal transducers TRAF2 and c- IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. USA 93: 13973-13978
212. Rothe M, Pan MG, Henzel WJ et al. (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252
213. Clem RJ (2001) Baculoviruses and apoptosis: the good, the bad, and the ugly. Cell Death Differ. 8: 137-143
214. Roy N, Deveraux QL, Takahashi R et al. (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16: 6914-6925
215. Wang CY, Mayo MW, Korneluk RG et al. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683
216. Yang Y, Fang S, Jensen JP et al. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288: 874-877
217. Huang H, Joazeiro CA, Bonfoco E et al. (2000) The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro ubiquitination of caspases-3 and -7. J. Biol. Chem. 275: 26661-26664
218. Luo X, Budihardjo I, Zou H et al. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490
219. Li H, Zhu H, Xu CJ and Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501
220. Chai J, Du C, Wu JW et al. (2000) Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855-862
221. Verhagen AM, Ekert PG, Pakusch M et al. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53
222. Wei MC, Zong WX, Cheng EH et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730
223. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933
224. Tang D, Lahti JM and Kidd VJ (2000) Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J. Biol. Chem. 275: 9303-9307
225. Engels IH, Stepczynska A, Stroh C et al. (2000) Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 19: 4563-4573
226. Wieder T, Essmann F, Prokop A et al. (2001) Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97: 1378-1387
227. Scaffidi C, Fulda S, Srinivasan A et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687
228. Schwenzer R, Siemienski K, Liptay S et al. (1999) The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is upregulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase. J. Biol. Chem. 274: 19368-19374
229. Chu ZL, McKinsey TA, Liu L et al. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA 94: 10057-10062
230. Kreuz S, Siegmund D, Scheurich P and Wajant H (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell Biol. 21: 3964-3973
231. Micheau O, Lens S, Gaide O et al. (2001) NF-kappaB signals induce the expression of c-FLIP. Mol. Cell Biol. 21: 5299-5305
232. Wu MX, Ao Z, Prasad KV et al. (1998) IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281: 998-1001
233. Wang CY, Guttridge DC, Mayo MW and Baldwin Jr AS (1999) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell Biol. 19: 5923-5929
234. Lee HH, Dadgostar H, Cheng Q et al. (1999) NF-kappaB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96: 9136-9141
235. Zong WX, Edelstein LC, Chen C et al. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13: 382-387
236. Stehlik C, de Martin R, Kumabashiri I et al. (1998) Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha- induced apoptosis. J. Exp. Med. 188: 211-216
237. Tamatani M, Che YH, Matsuzaki H et al. (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274: 8531-8538
238. Chen C, Edelstein LC and Gelinas C (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell Biol. 20: 2687-2695
239. Bernard D, Quatannens B, Vandenbunder B and Abbadie C (2001) Rel/NF-kappa B transcription factors protect against tumor necrosis factor (TNF)- related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1. J. Biol. Chem. 276: 27322-27328
240. Brunet A, Bonni A, Zigmond MJ et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868
241. Cardone MH, Roy N, Stennicke HR et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321
242. del Peso L, Gonzalez-Garcia M, Page C et al. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689
243. Lin Y, Devin A, Rodriguez Y, Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13: 2514-2526
244. Martinon F, Holler N, Richard C and Tschopp J (2000) Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 468: 134-136
245. Irmler M, Steiner V, Ruegg C et al. (2000) Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett. 468: 129-133
246. Barkett M, Xue D, Horvitz HR and Gilmore TD (1997) Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272: 29419-29422
247. Tang G, Yang J, Minemoto Y and Lin A (2001) Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol. Cell 8: 1005-1016
248. Arnold R, Liou J, Drexler HC et al. (2001) Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB. J. Biol. Chem. 276: 14675-14684
249. Hu WH, Johnson H and Shu HB (2000) Activation of NF-kappaB by FADD, Casper, and Caspase-8. J. Biol. Chem. 275: 10838-10844
250. Ravi R, Bedi A, Fuchs EJ and Bedi A (1998) CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. Cancer Res. 58: 882-886
251. Levkau B, Scatena M, Giachelli CM et al. (1999) Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat. Cell Biol. 1: 227-233
252. Bachelder RE, Ribick MJ, Marchetti A et al. (1999) p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J. Cell Biol. 147: 1063-1072
253. Yang DD, Kuan CY, Whitmarsh AJ et al. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865-870
254. Behrens A, Sibilia M and Wagner EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21: 326-329
255. Tournier C, Hess P, Yang DD et al. (2000) Requirement of JNK for stress-induced activation of the cytochrome c- mediated death pathway. Science 288: 870-874
256. Maundrell K, Antonsson B, Magnenat E et al. (1997) Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress- activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272: 25238-25242
257. Yamamoto K, Ichijo H and Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell Biol. 19: 8469-8478
258. Srivastava RK, Mi QS, Hardwick JM and Longo DL (1999) Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl. Acad. Sci. USA 96: 3775-3780
259. Kuan CY, Yang DD, Samanta Roy DR et al. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22: 667-676
260. Nishina H, Fischer KD, Radvanyi L et al. (1997) Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385: 350-353
261. Hochedlinger K, Wagner EF and Sabapathy K (2002) Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 21: 2441-2445
262. Liu H, Jones BE, Bradham C and Czaja MJ (2002) Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G257-G266
263. Liu H, Lo CR and Czaja MJ (2002) NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35: 772-778
264. Guo YL, Baysal K, Kang B et al. (1998) Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273: 4027-4034
265. Guo YL, Kang B and Williamson JR (1998) Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273: 10362-10366
266. Gabai VL, Mabuchi K, Mosser DD and Sherman MY (2002) Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid- dependent pathway in tumor necrosis factor-induced apoptosis. Mol. Cell Biol. 22: 3415-3424
267. Tang G, Minemoto Y, Dibling B et al. (2001) Inhibition of JNK activation through NF-kappaB target genes. Nature 414: 313-317
268. Javelaud D and Besancon F (2001) NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 20: 4365-4372
269. Muhlenbeck F, Haas E, Schwenzer R et al. (1998) TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase- dependent and caspase-independent pathways. J. Biol. Chem. 273: 33091-33098
270. Roulston A, Reinhard C, Amiri P and Williams LT (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273: 10232-10239
271. Lenczowski JM, Dominguez L, Eder AM et al. (1997) Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell Biol. 17: 170-181
272. Herr I, Wilhelm D, Meyer E et al. (1999) JNK/SAPK activity contributes to TRAIL-induced apoptosis. Cell Death Differ. 6: 130-135
273. Geleziunas R, Xu W, Takeda K et al. (2001) HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410: 834-838
274. Hatai T, Matsuzawa A, Inoshita S et al. (2000) Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J. Biol. Chem. 275: 26576-26581
275. Charette SJ, Lambert H, Landry J (2001) A kinase-independent function of Ask1 in caspase-independent cell death. J. Biol. Chem. 276: 36071-36074
276. De Smaele E, Zazzeroni F, Papa S et al. (2001) Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313
277. Sulciner DJ, Irani K, Yu ZX et al. (1996) rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell Biol. 16: 7115-7121
278. Schulze-Osthoff K, Beyaert R, Vandevoorde V et al. (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12: 3095-3104
279. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J and Kitamura M (2000) Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. J. Biol. Chem. 275: 12684-12691
280. Binder C, Schulz M, Hiddemann W and Oellerich M (1999) Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. Lab. Invest. 79: 1703-1712
281. Sidoti-de Fraisse C, Rincheval V, Risler Y et al. (1998) TNF-alpha activates at least two apoptotic signaling cascades. Oncogene 17: 1639-1651
282. Wong GH, Elwell JH, Oberley LW and Goeddel DV (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923-931
283. Wong GH and Goeddel DV (1988) Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242: 941-944
284. Leist M and Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2: 589-598
285. Holler N, Zaru R, Micheau O et al. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1: 489-495
286. Luschen S, Ussat S, Scherer G et al. (2000) Sensitization to death receptor cytotoxicity by inhibition of fas- associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J. Biol. Chem. 275: 24670-24678
287. Khwaja A and Tatton L (1999) Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274: 36817-36823
288. Vercammen D, Brouckaert G, Denecker G et al. (1998) Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188: 919-930
289. Li M and Beg AA (2000) Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J. Virol. 74: 7470-7477
290. Vercammen D, Beyaert R, Denecker G et al. (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187: 1477-1485
291. Kawahara A, Ohsawa Y, Matsumura H et al. (1998) Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143: 1353-1360
292. Hennet T, Bertoni G, Richter C and Peterhans E (1993) Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53: 1456-1460
293. Hennet T, Richter C and Peterhans E (1993) Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289: 587-592
294. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B et al. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267: 5317-5323
295. Leist M, Single B, Castoldi AF et al. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185: 1481-1486
296. Eguchi Y, Shimizu S and Tsujimoto Y (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57: 1835-1840
297. Ferrari D, Stepczynska A, Los M et al. (1998) Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during. J. Exp. Med. 188: 979-984
298. Ha HC and Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. USA 96: 13978-13982
299. D'Amours D, Sallmann FR, Dixit VM and Poirier GG (2001) Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J. Cell Sci. 114: 3771-3778
300. Los M, Mozoluk M, Ferrari D et al. (2002) Activation and Caspase-mediated inhibition of PARP: A molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol. Biol. Cell 13: 978-988
301. Schulze-Osthoff K, Krammer PH and Droge W (1994) Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13: 4587-4596
302. Obeid LM, Linardic CM, Karolak LA and Hannun YA (1993) Programmed cell death induced by ceramide. Science 259: 1769-1771
303. Wiegmann K, Schutze S, Machleidt T et al. (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015
304. Dressler KA, Mathias S and Kolesnick RN (1992) Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255: 1715-1718
305. Stoffel W (1999) Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo. Chem. Phys. Lipids 102: 107-121
306. Lozano J, Menendez S, Morales A et al. (2001) Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J. Biol. Chem. 276: 442-448
307. Strelow A, Bernardo K, Adam-Klages S et al. (2000) Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192: 601-612
308. Wiegmann K, Schwandner R, Krut O et al. (1999) Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. J. Biol. Chem. 274: 5267-5270
309. Schwandner R, Wiegmann K, Bernardo K et al. (1998) TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273: 5916-5922
310. Heinrich M, Wickel M, Schneider-Brachert W et al. (1999) Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18: 5252-5263
311. Bursch W (2001) The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8: 569-581
312. Stoka V, Turk B, Schendel SL et al. (2001) Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276: 3149-3157
313. Foghsgaard L, Wissing D, Mauch D et al. (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153: 999-1010
314. Guicciardi ME, Deussing J, Miyoshi H et al. (2000) Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106: 1127-1137
315. Deiss LP, Galinka H, Berissi H et al. (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15: 3861-3870
316. Guicciardi ME, Miyoshi H, Bronk SF and Gores GJ (2001) Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159: 2045-2054
317. Heller RA, Song K, Fan N and Chang DJ (1992) The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70: 47-56
318. Tartaglia LA, Rothe M, Hu YF and Goeddel DV (1993) Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73: 213-216
319. Vandenabeele P, Declercq W, Vanhaesebroeck B et al. (1995) Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154: 2904-2913
320. Bigda J, Beletsky I, Brakebusch C et al. (1994) Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180: 445-460
321. Grell M, Scheurich P, Meager A and Pfizenmaier K (1993) TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res. 12: 143-148
322. Medvedev AE, Sundan A and Espevik T (1994) Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur. J. Immunol. 24: 2842-2849
323. Grell M, Zimmermann G, Gottfried E et al. (1999) Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18: 3034-3043
324. Vercammen D,Vandenabeele P, Declercq W et al. (1995) Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine 7: 463-470
325. Schneider P, Schwenzer R, Haas E et al. (1999) TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur. J. Immunol. 29: 1785-1792
326. Eliopoulos AG, Davies C, Knox PG et al. (2000) CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol. Cell Biol 20: 5503-5515
327. Yeh WC, Itie A, Elia AJ et al. (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12: 633-642
328. Weitzman JB, Fiette L, Matsuo K and Yaniv M (2000) JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6: 1109-1119
329. Li ZW, Chu W, Hu Y et al. (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med 189: 1839-1845
330. Senftleben U, Li ZW, Baud V and Karin M (2001) IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity 14: 217-230
331. Yin L, Wu L, Wesche H et al. (2001) Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291: 2162-2165
332. Wang ZQ, Stingl L, Morrison C et al. (1997) PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11: 2347-2358
333. Beg AA, Sha WC, Bronson RT et al. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-170
334. Beg AA and Baltimore D (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784
335. Tsitsikov EN, Laouini D, Dunn IF et al. (2001) TRAF1 is a negative regulator of TNF signaling. Enhanced TNF signaling in TRAF1-deficient mice. Immunity 15: 647-657
336. Nakano H, Sakon S, Koseki H et al. (1999) Targeted disruption of TRAF5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl. Acad. Sci. USA 96: 9803-9808
337. Tada K, Okazaki T, Sakon S et al. (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF- kappa B activation and protection from cell death. J. Biol. Chem. 276: 36530-36534